This series on “Evolving Landscape of the Management of Glioblastoma” is edited by Rimas V. Lukas, Department of Neurology, Northwestern University, Chicago, IL, USA; Lou & Jean Malnati Brain Tumor Institute, Chicago, IL, USA.
We present a special series of Chinese Clinical Oncology addressing the evolving landscape of the management of glioblastoma (GBM). Over the past handful of years, the field has been witness to a tremendous number of advances in our understanding of this disease. Some, such as the incorporation of the molecular characteristics underpinning the biology of the disease have been incorporated into the World Health Organization (WHO) classification system for central nervous system tumors.
Section 1: Evolving Landscape of the Management of Glioblastoma
Introduction to the evolving landscape of the management of glioblastoma
A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma
Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies
Anti-angiogenic therapies in the management of glioblastoma
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results
Radiotherapy intensification for glioblastoma: enhancing the backbone of treatment
Section 2: International Perspective on the Management of Glioblastoma
An international perspective on the management of glioblastoma
Management of glioblastoma: a perspective from Lithuania
Management of glioblastoma: an Australian perspective
Management of glioblastoma: a perspective from Nigeria
Management of glioblastoma: a perspective from Mexico
The series “The Evolving Landscape of The Management of Glioblastoma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Rimas V. Lukas served as the unpaid Guest Editor for the series.